Clinical Trial Update: Ribavirin Compared With Standard Care in Treating Patients With Respiratory Syncytial Virus Following Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ribavirin with standard care for respiratory syncytial virus infection in patients after stem cell transplantation has completed. Sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Infection | Phase 3 | Status: COMPLETED